HuagongsheHuagongshe Chemistry Print Report · For research reference only
Triphenylphosphine → Morphine Oxycodone
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Triphenylphosphine | HCID 11776 | — |
| Reactant | ethyl N-ethoxycarbonyliminocarbamate | HCID 220568 | — |
| Reactant | Oxycodone | HCID 5284603 | — |
| Reactant | 3-Tert-butyldimethylsilylmorphine | HCID 131719973 | — |
| Reactant | HCID 178440551 | HCID 178440551 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | Morphine Oxycodone | HCID 9830161 | — |
Reaction Steps
To a solution of 3-tert-butyldimethylsilylmorphine (1 eq.) and the oxycodone-linker oxime from step 1 (1 eq.) in an anhydrous solvent such as THF (approximately 0.1 M) is added 2 equivalents of diethyl azodicarboxylate (DEAD) and 2 equivalents of triphenylphosphine. The resulting mixture is stirred at ambient temperature until the 3 -ten-butyldimethylsilylmorphine and/or the oxycodone-linker oxime is consumed, as monitored by TLC or HPLC. The resulting mixture is then subjected to an aqueous work up, and the product is purified by silica gel column chromatography or preparatory HPLC to provide the protected hybrid morphine-oxycodone compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08461171B2 |
| Source dataset | uspto-grants-2013_06 |
| ORD ID | ord-fb90de9e9e99472ca2ea8d3735335583 |
| Source note | uspto-grants-2013_06 |